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ABSTRACT
Patient-specific cardiac models can be used to improve the diagnosis of cardiovascular
diseases. However, practical application of these models is impeded by the computational
costs and numerical uncertainties of fitting them to clinical measurements from individual
patients. Reliable and efficient model tuning within medically-appropriate error bounds is a
requirement for practical deployment in the time-constrained environment of the clinic. In
this work, we present a framework to efficiently tune parameters of patient-specific mech-
anistic models using routinely acquired non-invasive patient data with a hybrid particle
swarm and pattern search optimization algorithm.
The proposed framework is used to tune full-cycle lumped parameter circulatory mod-
els using clinical data obtained from patients as well as canine subjects; showing that the
framework can be easily adapted to optimize cross-species models. It is also used to simul-
taneously obtain the unloaded geometry and passive myocardial material parameters of four
left-ventricular cardiac finite element models constructed from canine subject MRI data.
This demonstrates that the proposed approach can support the use of complex models to
obtain data that cannot be directly measured. The patients gave informed consent and
the canine subject studies were approved by the local Institutional Review Boards. The
optimized results in all case studies were within acceptable error tolerances.
Additionally, the framework is extended to include uncertainty quantification – support-
ing model tuning with often-unreliable data sources that are ill-suited to a deterministic
approach. The proposed approach for probabilistic model tuning discovers distributions
of model inputs which generate target output distributions. Probabilistic sampling is per-
formed using a model surrogate for computational efficiency and a general distribution
parameterization is used to describe each input. The approach is tested on four test cases
xii
using CircAdapt, a cardiac circulatory model. Three test cases are synthetic, aiming to
match the output distributions generated using known reference input data distributions,
while the fourth example uses real-world patient data for the output distributions to obtain
the input distribution. The results demonstrate accurate reproduction of the target output
distributions, with accurate recreation of reference inputs for the three synthetic examples.
Overall, this work automates the use of biomechanics and circulatory cardiac models
in both clinical and research environments by ameliorating the tedious process of manually
fitting model parameters and supports the use of more complex models in practice through
the quantification of error.
1CHAPTER 1. INTRODUCTION
Cardiovascular disease (CVD) has been the leading global cause of death for the last
decade, causing roughly a third of total deaths in 2010 (World Health Organization, 2008).
Mortality rates due to CVD have risen owing to lifespan increases in high-income coun-
tries (The World Bank, 2012). The United States, for example, spent an estimated $193
billion on the treatment of CVD and stroke between 2011 and 2012, more than double the
treatment cost of cancer. An additional $123 billion of future productivity was lost due to
premature deaths (Fuchs and Milstein, 2011).
The cost of treating CVD in the US is significantly higher, for sub-par life expectancy,
than other high-income countries (Mozaffarian et al., 2015). Efforts to improve treatment
efficiency, such the American College of Cardiologys Appropriate Use Criteria for cardiovas-
cular technology (Hendel et al., 2013), are hamstrung by limited adherence to clinical best
practices (Mehta et al., 2007). As an example, only 66.5% of coronary artery disease pa-
tients received the optimal evidence-based combination of treatments during their first visit
in 2013 (Maddox et al., 2014). Aside from missed treatment opportunities, these therapies
have a large societal cost in the form of adverse drug reactions and unnecessary resource
use (Landrigan et al., 2010). Consistent evaluation of treatment value and risk is necessary
to correct these inefficiencies; however, the aggregate value of potential outcomes can be
complicated to define or evaluate (Porter, 2010).
Patient data is widely used to improve risk classification and treatment based on pop-
ulation statistics (Gaziano et al., 2005; Ferrario et al., 2005; Wilson et al., 1998). While
certain acute medical episodes may have clearly preferred treatment strategies, preventa-
2tive procedures and the management of chronic illness often involve subjective trade-offs.
In these cases, there are often important details in patient data that could impact diagno-
sis. Unfortunately, declines in cardiac examination skills (Vukanovic-Criley et al., 2006) and
patient-physician interaction time (Dugdale et al., 1999) have led to a decrease in diagnostic
accuracy.
Computer-based decision support systems offer an opportunity for improved treatment
efficiency. These technologies are often minimally invasive and make use of commonly
recorded medical data to supplement understanding of a patients condition. Future versions
of these models could suggest alternate diagnoses and treatments informed by the rapid
developments in machine learning techniques. Physical models have been a foundational
category of computer-based medical decision aids for at least 30 years (Shortliffe et al., 1979),
and advances in algorithms and computing power continue to improve the tractability of
higher-fidelity analysis (Baillargeon et al., 2014). However, while computational models can
be used to more efficiently and thoroughly understand a complex system than experiments at
a reduced cost, many components require manual or automated tuning of model parameters
to properly capture the modeled system.
The deployment of more complex models is currently limited by the expensive tuning of
many patient-specific parameters and the level of training required to initialize and operate
them. Additionally, the values of these parameters are often determined using experimental
or reference data, either directly or indirectly via dependent model values. Available data
is often unreliable which impedes consistent tuning and must be accounted for to fully
determine the accuracy of a result.
I propose an optimization-based framework to support the wider application of patient-
specific physical models to the treatment of CVD. Optimization provides a useful framework
to bridge the gap between available models and patient data by automating the parameter
selection process. The main contributions of this dissertation include the development of:
31. A framework to automatically tune biomechanics and circulatory cardiac
models using patient-specific data
Cardiovascular applications of optimization have focused on shape optimization of
cardiac geometry using idealized template meshes. Recently, biomechanics and cir-
culatory models have increased in complexity, allowing them to capture the physics
more accurately. However, improvements in optimization methodologies have not been
widely applied specifically to parameter estimation of these physics models. Marsden
et al. (2008) used the surrogate management framework (SMF) for shape optimization
with a general biophysical model. Agoshkov et al. (2006) used an adjoint approach
to geometrically optimize an idealized model of cardiac anastomosis. Krishnamurthy
et al. (2013) hand-tuned a model of ventricular inflation with patient-specific geom-
etry to determine cardiac tissue material parameter inputs of a circulatory model. I
created an optimization framework to tune the parameters of biomechanics and cir-
culatory cardiac models based on patient-specific data, allowing physicians to more
broadly apply these models in a clinical setting.
2. A reliable optimization formulation to fit parameters of full cardiac-cycle
circulatory models
Most previous applications of optimization to circulatory model parameter fitting
have used a localized or gradient-based approach; however, derivative-free and heuris-
tic methods are more suitable for complex, multimodal models. Neal and Bassingth-
waighte (2007) used the Nelder-Mead Simplex algorithm (NMS) to tune two open-loop
models of hemorrhage in porcine subjects. Lim et al. (2010) applied NMS to explore
a lumped parameter model of an implantable rotary blood pump under various oper-
ating conditions. Ellwein et al. (2013) used the gradient-based LevenbergMarquardt
algorithm to fit a lumped-parameter model of congestive heart failure. I demonstrate
an efficient and reliable algorithm for optimizing full-cycle circulatory models that can
work for a wide variety of patients.
43. A methodology suitable for treatment and study utilizing cross-species
models
Medical scientists commonly use animals to perform research more feasibly than could
be done with human patients (Leong et al., 2015). Different animal models are val-
ued for the study of specific aspects of cardiac function (Milani-Nejad and Janssen,
2014), necessitating the development of consistent study methodologies to compare
results. Most cross-species research has focused on the study of drug response in
living subjects; computerized biophysical models are a less mature field and are thus
still establishing best practices. I show that the proposed framework can be used to
consistently analyze models of both human patients and canine subjects, validating
its suitability for cross-species research.
4. A platform for uncertainty quantification (UQ) of patient-specific biophys-
ical models
Physicians cannot rely on models unless the error of a simulated result is quantified.
Analysis of parameter sensitivity can be used to obtain this information or provide a
more robust solution. These techniques are mature, but have not been widely applied
to patient-specific models. Sankaran et al. (2013) modeled the long-term adaptation of
blood vessels by robustly optimizing arterial wall properties of an idealized geometry
using SMF with a stochastic cost function. Probst et al. (2010) studied the sensitiv-
ity of idealized bypass geometry to blood viscosity inputs by computing derivatives
of geometric parameters. Huberts et al. (2018) propose a method to make uncertain
cardiovascular models more useful for diagnosis and intervention based largely on sen-
sitivity analysis. Sankaran and Marsden (2011) perform UQ for a variety of geometric
cardiovascular models using a stochastic collocation approach. I describe and test an
appropriate method of UQ for patient-specific biophysical models as a foundational
step towards quantifying the confidence in their results.
5This work facilitates the use of biomechanics and circulatory cardiac models by address-
ing the currently most challenging aspects of the process. Researchers will also be able to
build on this framework to compare data between cross-species models and further advance
medical understanding. Chapter 2 introduces the deterministic portion of the framework.
In Chapter 3, it is extended to include uncertainty quantification. Finally, Chapter 4 sum-
marizes results and limitations and highlights potential avenues of improvement.
6CHAPTER 2. OPTIMIZATION FRAMEWORK FOR
PATIENT-SPECIFIC CARDIAC MODELING
This paper is in review for Biomechanics and Modeling in Mechanobiology. It was
authored by Joshua Mineroff, Andrew D. McCulloch, David Krummen, Baskar Ganapa-
thysubramanian, Adarsh Krishnamurthy. I was responsible for developing, implementing,
and testing the framework as well as for writing the majority of the manuscript. Andrew and
David offered expertise on cardiovascular disease and treatment. Baskar contributed to the
methodological decisions pertaining to optimization. Adarsh helped create the methodology
and informed relevance to the field of cardiac modeling.
2.1 Abstract
Patient-specific models of the heart can be used to improve the diagnosis of cardiac
diseases, but practical application of these models can be impeded by the computational
costs and numerical uncertainties of fitting mechanistic models to clinical measurements
from individual patients. Reliable and efficient tuning of these models within clinically ap-
propriate error bounds is a requirement for practical deployment in the time-constrained
environment of the clinic. We developed an optimization framework to efficiently tune
parameters of patient-specific mechanistic models using routinely-acquired non-invasive pa-
tient data. We employ a hybrid particle swarm and pattern search optimization algorithm,
but the framework can be readily adapted to use other optimization algorithms. We apply
the proposed framework to tune full-cycle lumped parameter circulatory models using clin-
ical data obtained from patients who gave informed consent. We show that our framework
7can be easily adapted to optimize cross-species models by tuning the parameters of the
same circulation model to four canine subjects. Finally, to demonstrate the framework’s
extensibility to more sophisticated models, we use it to simultaneously obtain the unloaded
geometry and optimize the passive myocardial material parameters of four left-ventricular
cardiac finite element models constructed from canine subject MRI data. The simulated
end-diastolic pressure-volume relationships were optimized to match previously established
relationships from literature (Klotz et al., 2006); and were all within acceptable error tol-
erances. This work will facilitate the use of biomechanics and circulatory cardiac models
in both clinical and research environments by ameliorating the tedious process of manually
fitting the parameters.
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82.3 Introduction
Cardiovascular disease (CVD) has been the leading cause of death globally for the last
decade, causing roughly a third of all-cause deaths in 2013 (Roth et al., 2015). Efforts to
improve treatment efficiency, e.g. the development of appropriate use criteria for cardiovas-
cular technology (Hendel et al., 2013), have been hamstrung by limited adherence to clinical
best practices (Mehta et al., 2007) mainly due to the complicated nature of CVD, declines
in cardiac examination skills (Vukanovic-Criley et al., 2006), and reduced patient-physician
interaction time (Dugdale et al., 1999). As an example, only 66.5% of coronary artery dis-
ease patients received the optimal evidence-based combination of treatments during their
first visit in 2013 (Maddox et al., 2014). Suboptimal initial treatment increases effective
time-to-treatment, further contributing to CVD mortality rates (Nallamothu et al., 2015;
Ting et al., 2010). Patient-specific computer-based decision support systems offer an op-
portunity for improved treatment efficiency through better diagnosis based on mechanistic
models tuned to the individual patient.
Physical models have been a foundational category of computer-based medical decision
aids for at least 30 years (Shortliffe et al., 1979) and advances in algorithms and com-
puting power continue to improve the tractability of higher-fidelity analysis (Baillargeon
et al., 2014). Specifically, patient-specific computer-based decision support systems often
make use of commonly recorded medical data to assist clinical diagnosis or therapy plan-
ning. Graphical decision aids have also been found to improve comprehension when used
to supplement physician-patient discussions (Stacey et al., 2017; Hess et al., 2012; Arnold
et al., 2008). As an example, cardiac pressure-volume (P-V) loops are an effective tool for
the identification of cardiac pathologies, since cardiologists are trained to diagnose different
pathological conditions using them. P-V loops of the ventricular chambers are traditionally
unobtainable without catheterization, but computational mechanistic models can estimate
P-V loops of each chamber of the heart using only non-invasive measurements.
9Patient data is widely used for risk classification and forecasting of treatment outcomes
based on population statistics (Gaziano et al., 2005; Ferrario et al., 2005; Wilson et al.,
1998); patient-specific modeling is the process of using these data to individualize general
computational models to integrate clinical data and use prior physiological knowledge and
physicochemical constraints to make individualized predictions and decisions. However, the
deployment of complex patient-specific models is currently limited by the level of training
required to initialize and operate them. Individualizing a complex model for a wide variety
of patients is often hindered by gaps in available patient data, which necessitate the use
of empirical data or rules to tune model parameters. Reliable and efficient tuning of these
models is a requirement for deployment in the environment of a medical clinic, but the
manual tuning process can be imprecise and time-consuming.
In order to reduce the manual tuning required for patient-specific modeling, we pro-
pose an optimization-based framework to support the wider application of patient-specific
physical models to the treatment of CVD. Optimization bridges the gap between available
complex models and patient data by automating the fitting process and providing a con-
sistent, resource-efficient result. Manual tuning relies heavily on the user’s experience with
the model, and modeled system, to select appropriate parameters; this often leads to local
optima that are unnecessarily close to initially-assumed parameter values. Computerized
optimization can systematically search the feasible region more efficiently, often running
many evaluations in parallel, to find better solutions.
We test this framework using two examples: a left ventricular (LV) passive finite-element
model and a hemodynamic lumped-parameter circulation model. The FEA model is used
to determine the unloaded geometry and the cardiac tissue material parameters of four
canine subjects based on data made available from a previous benchmark study (Wang
et al., 2009). The circulation model is then used to personalize the hemodynamics of the
four canine subjects to generate P-V loops of the different chambers of the heart. The
framework is then used to determine the hemodynamic parameters of eight human patients
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using only limited non-invasive measurements. This demonstrates the broad applicability
of the proposed method in handling different mechanistic models in different species.
The main contributions of this work include the development of:
1. A framework to automatically tune biomechanics and circulatory cardiac models using
patient-specific data with minimal user intervention.
2. A robust optimization formulation to fit parameters of full cardiac-cycle circulatory
models, even with missing clinical data in certain patients.
3. A methodology that is applicable for different types of mechanistic models and enable
automatic tuning of cross-species models.
Our optimization framework can be used by researchers who can treat the mechanistic
models as a black-box. It will facilitate the use of biomechanics and circulatory cardiac mod-
els in both clinical and research environments by ameliorating the tedious and potentially
biased process of manually fitting the parameters.
2.4 Related Work
Recently, cardiovascular models have increased in complexity, allowing them to capture
the relevant physics more accurately. Highly sophisticated models exist for many biophysical
cardiac phenomena, (Niederer et al., 2009) and treatment options (Kerckhoffs et al., 2008).
These models require extensive patient data and are already being tested in clinical settings.
Smith et al. (2011) are developing one such example of a data driven-model for the optimal
application of treatment modalities.
Cardiovascular applications of optimization to biomechanics and circulatory models have
focused on shape optimization of cardiac geometry using idealized template meshes. How-
ever, improvements in optimization methodologies have not been widely applied specifically
to parameter estimation of these physics models. Marsden et al. (2008) used the surrogate
management framework (SMF) for shape optimization with a general biophysical model.
11
Agoshkov et al. (2006) used an adjoint approach to geometrically optimize an idealized
model of cardiac anastomosis. Krishnamurthy et al. (2013) hand-tuned a model of ventric-
ular inflation with patient-specific geometry to determine cardiac tissue material parameter
inputs of a circulatory model.
Closed-loop circulatory models provide valuable insight into cardiac function. Early
circulatory models were limited to small sections of the cardiovascular system (Hardy et al.,
1982), but increases in computing power enabled the development of more complete models.
For example, Olansen et al. (2000) constructed an integrative model using reference values
to study the effects of small parameter perturbations. This model, and others like it,
were primarily valuable as a tool to develop and test general physiological principles. The
CircAdapt model consists of an idealized set of active components (i.e. tubes, chambers,
and valves) that are governed by empirical and patient-specific data (Arts et al., 2005).
Most previous applications of optimization to circulatory model parameter fitting have
used a localized or gradient-based approach; however, derivative-free and heuristic methods
are more suitable for complex, multi-modal models where gradient-evaluation is expen-
sive and there are many local optima that confuse the solver. Neal and Bassingthwaighte
(2007) used the Nelder-Mead Simplex algorithm (NMS) to tune two open-loop models
of hemorrhage in porcine subjects. Lim et al. (2010) applied NMS to explore a lumped
parameter model of an implantable rotary blood pump under various operating condi-
tions. Ellwein et al. (2013) used the gradient-based Levenberg-Marquardt algorithm to fit
a lumped-parameter model of congestive heart failure.
Medical science commonly uses animals to perform research more feasibly than could be
done with human patients (Leong et al., 2015). Different animal models are valued for the
study of specific aspects of cardiac function (Milani-Nejad and Janssen, 2014), necessitating
the development of consistent study methodologies to compare results. Most cross-species
research has focused on the study of drug response in living subjects; computerized bio-
physical models are a less mature field and are thus still establishing best practices.
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We created an optimization framework to tune the parameters of biomechanics and
circulatory cardiac models generated using patient-specific data, allowing physicians to more
broadly apply these models in a clinical setting. The burden of parameter tuning is reduced
by using adaptation rules to propagate changes through the model, making CircAdapt (Arts
et al., 2005) an especially tractable patient-specific model. We demonstrate an efficient and
reliable algorithm for optimizing full-cycle circulatory models and show that the proposed
framework can be used to consistently analyze models of both human patients and canine
subjects, validating its suitability for cross-species research.
2.5 Methods
2.5.1 Optimization framework
Our framework is designed to perform parameter optimization to tune patient-specific
computerized biophysical models to available data. The multi-modal, highly corrugated
nature of these models makes it difficult to compute gradients and favored a derivative-
free approach. We selected a hybrid particle swarm and pattern search solver to globally
search the parameter space and support parallel model evaluation. Since model analysis is
the primary computational expense for this class of problems, the potential overhead of a
higher-level software package is insignificant.
Particle swarm optimization (PSO) is a heuristic method using a population of candidate
solutions, referred to as particles (Shi and Eberhart, 1998). Initially, these particles are
distributed throughout the parameter space with a given location and ’velocity.’ A step
of the algorithm starts with the evaluation of the current parametric configuration of each
particle. Then, the velocities of each particle are updated as a function of (1) its current
velocity, (2) the best solution that it has found, and (3) the best solution any particle
has found. The algorithm continues until a termination criteria is met, usually when a set
number of iterations have passed without improving the objective value by a given tolerance.
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One of the primary benefits of PSO is its fast convergence in global search for traditionally
difficult problems, but it is an expensive method for computing precise optima.
Pattern search is a direct search method (DS) involving the use of a scalable pattern,
or mesh, to step through the parameter space from an initial location (Hooke and Jeeves,
1961). At each iteration, the mesh is centered at the current best point and parameter
values at the surrounding mesh points are evaluated. The specific mesh pattern used polls
a positive and negative perturbation of every parameter at each iteration. If an improvement
is found, the mesh is re-centered at the new location and expanded to minimize the chances
of convergence to a non-global minimum. If no improvement is found, the mesh is contracted
to more precisely identify the local optimum. DS methods are highly influenced by initially
assumed parameter values, but are one of the most efficient non-analytical methods for the
identification of a precise solution.
The full hybrid algorithm we employed first searches the solution space using PSO to
identify a likely global optima. The resulting solution was then used to initialize the DS
method to more efficiently find a precise optimum. It is generally impossible to prove that
the true global optimum has been identified for non-analytical multi-modal problems, but
in our experience, this approach converged to an acceptable result within the bounded
parameter space for a majority of the runs.
All optimization and analysis was run on a cluster with each node having two 2.6 GHz
8-Core Intel E5-2640 v3 processors and 128GB of RAM. The framework is implemented
in MATLAB (MathWorks, 2017), since it has multiple commercially-tested derivative-free
solvers and is capable of integrating with most models, and will be made available after
publication. The primary computational expense for the kind of optimization problems
studied in this paper are the many model evaluations required. Both optimization methods
used in our approach are well-suited to parallelization which can decrease the wall time
of the optimization by allowing a larger pool of computational resources to be used than
could be applied to a single evaluation. This is especially attractive with the increasing use
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of cloud computing. Parallelization was handled differently for each model and is further
explained in each section.
2.5.2 Clinical data
The eight human patients studied were male, aged (66± 11 years) with NYHA class III
heart failure, dilated cardiomyopathy, and left bundle branch block (LBBB) were enrolled
from the Veteran’s Administration San Diego Healthcare System (San Diego, CA). Patients
gave informed consent to participate in the human subject protocol approved by the insti-
tutional review board. Key cardiac measurements were recorded via echocardiogram and
routine diagnostic methods; pressure data from cardiac catheterization was also used for
validation.
The canine simulations used four normal dog data provided by the STACOM 2014
LV Mechanics Challenge (Camara et al., 2014). The data was acquired at the National
Institute of Health, USA in collaboration with Johns Hopkins University (Ennis, 2004)
using high resolution cines, tagging, and ex-vivo diffusion tensor imaging (DTI) (Wang et al.,
2009). Data acquisition was approved by local Institutional Review Boards and conducted
in accordance with the “Guide for the Care and Use of Laboratory Animals” (Institute
of Laboratory Animal Resources (ILAR), 1996). In-vivo left ventricular pressures were
also recorded during scanning. Dogs were paced from the right atrium. The processed
data included mesh point clouds and binary masks defining the LV geometry and muscle
fiber orientations derived from ex vivo diffusion tensor MRI. The geometries only reflect
the location of the epicardial and endocardial surfaces; they do not encode material point
displacements. The finite element geometry for the dog models were reconstructed using
the methods outlined in Krishnamurthy et al. (2015).
15
50 100 1500
5
10
15
20
2.5
Volume (mL)
P
re
s
s
u
re
 (
k
P
a
)
LV
P
min
EDP
M
it
ra
l
R
e
g
u
rg
it
a
ti
o
n
EDV
P
max
A B
LV RV
LA RA
Pulm. Syst.
Data/ref Parameters
Figure 2.1 The geometric parameters and objective metrics used in the circulatory opti-
mization. (A) A schematic of the CircAdapt model highlighting key geometric
dimensions of major model components. A subset of the model values directly
driven by patient-specific or reference data (Table 2.1) and the parameters used
(Table 2.3) are both shown. (B) A typical simulated left ventricular (LV) pres-
sure-volume loop showing all partial objective metrics. Pulm. = pulmonary
circulation; Syst. = systemic circulation; LA = left atrium; RA = right atrium;
RV = right ventricle; EDV = end-diastolic volume; EDP = end-diastolic pres-
sure.
2.5.3 Circulation model
CircAdapt (Arts et al., 2005) is a lumped-parameter model of the circulatory system
(Fig. 2.1) implemented in MATLAB. It can be used to model the pressure and volume of
the four chambers as a function of time for the complete cardiac cycle. We use CircAdapt
to perform a closed-loop simulation of the patient-specific cardiovascular system, incorpo-
rating up to 11 values of non-invasively obtained patient data, and output one simulated
cycle of blood flow. The potential data include heart rate and blood pressure, as well as
valve measurements that can be obtained through ECG or echocardiogram (Table 2.1).
Basic canine subject data was also used (Table 2.2). A subset of seven CircAdapt model
parameters were selected for tuning (Table 2.3).
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Table 2.2 Experimentally measured objectives for canine subjects studied in circulatory
optimization. All subject models relied largely on reference data. PmaxLV =
peak left-ventricular pressure; EDVLV = left-ventricular end-diastolic volume.
Subject PmaxLV EDVLV
(kPa) (mL)
S1 13.6 30.3
S2 12.3 20.5
S3 10.3 24.5
S4 11.3 19.6
Primary model fit was assessed as a function of the relationships of simulated peak
pressure (Pmax, Eq. 2.1) and end-diastolic volume (EDV, Eq. 2.2) to measured patient
values, with additional constraints that are enforced as penalties to the objective func-
tion. These penalties were based on (1) minimum LV pressure (Pmin: 0.5 kPa, Eq. 2.3),
(2) LV end-diastolic pressure (EDP: 2.5-4 kPa, Eq. 2.4), and (3) mitral regurgitant volume
(MRV, Eq. 2.5). The component weights of the objective function were selected to prior-
itize those with greater certainty and reduce those relying on assumptions from reference
data. The contribution of constraints on Pmin and EDP were minimized the most, as they
were not derived from patient data, while Pmax was weighted highly, as it was measured
most directly. Additionally, positive Pmax and EDV model error were penalized by a factor
of 2 to account for possible measurement overestimation (Piper et al., 2015; Lang et al.,
2006). If no MRV patient data was available, then a healthy reference value of 30 mL was
used as an upper bound; 3 mL was used for the canine subjects. Our framework could be
easily adapted to use other objective functions motivated by biomechanical principles or
physiology (e.g. Heusinkveld et al. (2009)).
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Table 2.3 Parameters and bounds of the different optimization variables in x of the circu-
lation model.
Variable Description Lower
Bound
Upper
Bound
Units Reference
kMAP Scaling of mean arterial pres-
sure initially calculated using
the ’33% formula’
0.8 1.2 - (Raamat et al.,
2013)
P∆pulm Blood pressure head loss across
the pulmonary system
0.5 1.5 kPa (Yoshimura
et al., 1993;
Nauser and
Stites, 2001)
Laorta Geometric scaling factor of ef-
fective length of aorta from Cir-
cAdapt reference configuration
0.5 1.5 -
Lpulm Geometric scaling factor of ef-
fective length of pulmonary
artery from CircAdapt reference
configuration
0.5 1.5 -
kLV Geometric scaling factor of left
ventricular midwall surface area
from CircAdapt reference con-
figuration
0.5 2 - (Clay et al.,
2006)
kRV rel Geometric scaling factor of right
ventricular midwall surface area
from CircAdapt reference con-
figuration relative to left ventri-
cle scaling
0.5 2 - (Kovalova et al.,
2006)
Sfact Maximum isometric active
stress of myofibers
25 200 kPa
Sfpas Passive stiffness of myofibers 10 30 kPa
Mleak Ratio of mitral valve leak area
to open area
1e-6 0.2 - (Zoghbi, 2016)
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yPmax(x) =

(
Pmax(x)−Pmaxdata
Pmaxdata
)2
,
if Pmax(x) ≤ Pmaxdata
2 ∗
(
Pmax(x)−Pmaxdata
Pmaxdata
)2
,
if Pmax(x) > Pmaxdata
(2.1)
yEDV (x) =

(
EDV (x)−EDVdata
EDVdata
)2
,
if EDV (x) ≤ EDVdata
2 ∗
(
EDV (x)−EDVdata
EDVdata
)2
,
if EDV (x) > EDVdata
(2.2)
gPmin(x) =
(
Pmin(x)− Pminref
Pmaxdata − Pminref
)2
,
if Pmin(x) > Pminref
(2.3)
gEDP (x) =

(
EDP (x)−EDPrefmin
Pmaxdata−Pminref
)2
,
if EDP (x) ≤ EDPrefmin(
EDP (x)−EDPrefmax
Pmaxdata−Pminref
)2
,
if EDP (x) > EDPrefmax
(2.4)
gMRV (x) =

(
MRV (x)−MRVdata
MRdata
)2
,
if MRVdata 6= ∅(
MRV (x)−MRVref
MRref
)2
,
if MRVdata = ∅
and MRV (x) > MRVref
(2.5)
The complete optimization formulation (Eq. 2.6) was used to generate CircAdapt models
for eight human patients and four canine subjects. This resulted in 45 (5N) evaluations for
20
each PSO iteration and 18 (2N) iterations for each DS iteration. Each optimization was run
in a MATLAB environment on one 16-core node, allowing for 16 parallel single-threaded
evaluations. Repeated parameter configurations used the initial result for improved effi-
ciency.
arg min
x
(
0.8 ∗ yPmax(x) + 0.2 ∗ yEDV (x)
+ 0.75 ∗ gPmin(x) + 0.75 ∗ gEDP (x)
+ 0.15 ∗ gMRV (x)
)
s.t. E(P (x), V (x)) = 0, (ODE Solution),
Ax ≤ b, (Bounds on x)
(2.6)
2.5.4 Finite-element model
We use a finite-element model of the canine left ventricle to determine its unloaded
state and personalized material parameters of the cardiac tissue. An analysis-suitable left
ventricular mesh is constructed from an MRI scan of the subject or patient heart at end-
diastole. However, since this mesh is measured at the loaded state, an unloaded mesh state
needs to be determined along with the properties of the passive Ogden-Holzapfel material
model (Holzapfel and Ogden, 2009).
The unloaded mesh is obtained through an iterative inflation-deflation process. We first
assume an initial unloaded geometry state that is identical to the MRI mesh, and passively
inflate it to the measured EDP. Then the deformation gradient between the loaded and
MRI mesh is inversely applied to the unloaded geometry. This process is repeated until the
interior volume of the loaded mesh and MRI mesh converge to within 3% (Krishnamurthy
et al., 2016).
ψ =
a
2b
eb(I1−3) +
∑
i=f,s
ai
2bi
(ebi(I4i−1) − 1) + afs
2bfs
(ebfsI
2
8fs − 1) (2.7)
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Table 2.4 Parameters and bounds of coefficients of x in Eq. 2.9
a af b bf
(kPa) (kPa) - -
Upper Bound 50 50 50 50
Reference 1.5 15 8 15
Lower Bound 0.01 0.01 0.01 0.01
Four material model parameters (a, b, af , and bf , Table 2.4) are used to represent
patient-specific material properties in a simplified form of the Ogden-Holzapfel strain en-
ergy function (Eq. 2.7). Correctness of the material parameters is determined by the con-
formation of the resulting inflated ventricle to the reference end-diastolic pressure-volume
relationship (EPDVR) described by Klotz et al. (2006). This method uses the sole original
end-diastolic pressure (EDP) and volume (EDV) data point to describe the entire EDPVR
as a function (Eq. 2.8) with patient-specific values α and β. The least squares error is then
calculated between this curve and the complete set of data captured during the simulated
inflation (Fig. 2.2). The optimized material parameter values are those that minimize this
error (Eq. 2.9). We used four meshes generated from canine subjects to demonstrate the
approach.
EDPi = α ∗ EDV βi (2.8)
arg min
x
n∑
i=1
(Pi(x)− α(x)EDVi(x)β(x))2
s.t. E(V (x)) = 0, (PDE Solution),
Ax ≤ b, (Bounds on x)
(2.9)
Evaluation of this model is significantly more expensive than the circulation model,
and is therefore optimized using only the more computationally efficient DS portion of the
optimization framework. This shows how the exact implementation of the framework can
be easily adapted to different problems. The MATLAB-based DS optimization framework
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Figure 2.2 A representative example of both mesh states of the finite-element optimization
and the resulting EDPVR curve. (A) A converged unloaded and inflated mesh
from the simulation showing the change in ventricular shape and volume. (B)
A comparison of the precomputed Klotz curve and simulated pressure-volume
curve. EDPVR = end-diastolic pressure-volume relationship.
generated eight (2N) parameter configurations for each mesh iteration of the optimization
algorithm. The evaluation of these was handled via a queue managed by GNU Paral-
lel (Tange, 2011) to run up to eight evaluations in parallel across four nodes. A bash script
was used to control the inflation/deflation cycle until the model had converged. Each simu-
lation was performed using Continuity 6.4 (CMRG, 2015), a Python-based multi-scale FEA
and modeling tool developed by the UCSD Cardiac Mechanics Research Group, in parallel
across eight cores. This approach is highly scalable with a minimal amount of overhead.
2.6 Results
2.6.1 Circulation model results
Patient-specific circulatory models were tuned for the eight human subjects using Cir-
cAdapt with the presented optimization framework to determine parameter values (Ta-
ble 2.5). The pressure error for the eight patients had a max of 0.53% and a mean of 0.15%.
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Volume error had a max of 6.71% and a mean of 1.26%. Only the models for patients A
and E exceeded the reference minimum pressure value of 1 kPa, with patient E having the
highest value of 1.18 kPa, but all models had acceptable EDP values within 18% of the 2.5
kPa reference value. Mitral regurgitant volume was within 1.3 mL of the measured value
for two of the patients where that data was available (B and D), and within the (< 30
mL) healthy range for patients that did not have that data. The low measured regurgitant
volume (5 mL) of patient E was not able to be satisfied, contributing significantly (30%) to
the objective value.
The tuned models for patients A and E had significantly higher optimized objective
values than the other six patients (0.21e-3 and 1.23e-3 respectively, compared to the overall
median of 6.4e-8), primarily from EDV error. The model for patient F was the best op-
timization result, with an objective value of 6e-9. Parameter values were not consistently
bounded and were typically distributed through the allowable range. None of the left ven-
tricular P-V loops from each of the tuned models (Fig. 2.3) have any obvious artifacts that
would signify errors in CircAdapt model convergence.
CircAdapt models were also tuned for four canine subjects (Table 2.5), generating a
set of P-V loops (Fig. 2.4). The objective values for these models were higher on average
than the human patients (1.95e-3 vs. 1.8e-4). The primary source of errors varied across
subjects, with S1 being most affected by Pmax and S3 being most affected by EDP and
Pmin.
The average time to solution was 29 hrs, with a range of 25-40 hrs. The average num-
ber of model evaluations was 3875, ranging from 2257 to 5454; 8% of these were repeat
configurations which used the previously logged result for efficiency.
Both sets of circulatory results were validated by calculating the root-mean-square error
(RMSE) between the simulated pressure curves and the left ventricular catheter data that
was available for the eight patients. The result highlights a potential downside of only using
non-invasive measurements, because systolic cuff pressure data for the studied patients
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Figure 2.3 Left ventricular pressure-volume loops for the eight human patients.
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Figure 2.4 Left ventricular pressure-volume loops for the four canine subjects.
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Figure 2.5 Validation of the simulated left ventricular pressure curves for the eight human
patients with catheter data after optimizing based on the peak catheter pres-
sure. Gray lines show cuff measurement systolic and diastolic pressures - only
catheter pressure was available as the reference for Patient H.
differed from peak left ventricular catheter pressure by an average of 41%. Substituting
the LV catheter pressure for cuff pressure as the optimization input reduced RMSE by
an average of 31%; patient E error decreased by 69% (Figure 2.5). It must be noted
that catheter measurements are not routinely performed on heart failure patients. We tried
several different approaches to get an effective simulated pressure time-course in the absence
of reliable, invasive pressure data; we discuss these approaches in detail in the Supplement.
The approach that gave the best result was to optimize the patients using the cuff systolic
pressure first and then replacing the MAP and Sfact for all patients with an average value
(Figure 2.6). This method reduced the RMSE error for most patients except for patient G
and H (Table 2.6).
Since cuff pressure was not available for the canine subjects, catheter data was used as
a direct optimization input. This led to a lower average RMSE than for the non-invasive
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Figure 2.6 Validation of the simulated left ventricular pressure curves for the eight human
patients with catheter data after tuning the optimized results with the average
MAP and Sfact. Gray lines show cuff measurement systolic and diastolic
pressures - only catheter pressure was available as the reference for Patient H.
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Figure 2.7 Validation of the simulated left ventricular pressure curves for the the four ca-
nine subjects with catheterized in-vivo pressure data. Gray line shows reference
catheter pressure.
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Table 2.6 RMSE between both human and canine model and catheter data when either
cuff (with or without using the mean values of MAP and Sfact) or catheter
pressure is used as an optimization input.
Subject/ Cuff Mean Cath
Patient (kPa) (kPa) (kPa)
A 4.07 2.90 2.41
B 2.66 2.57 2.75
C 2.85 2.53 2.78
D 4.59 4.08 3.28
E 3.11 1.53 0.97
F 3.48 3.29 1.43
G 2.79 4.44 1.39
H 1.42 1.55 1.42
S1 - - 1.30
S2 - - 1.41
S3 - - 1.11
S4 - - 2.72
human patient results (1.6 kPa vs. 3.12 kPa, Fig. 2.7). One of the largest contributors to
the calculated RMSE values was inaccuracy in the total time of cardiac tissue activation.
This value was not a parameter in the optimization, since there was no available patient
data to evaluate it against, and thus remained at the typical reference value. Table 2.6
shows the RMSE values for each subject and each patient when optimized with cuff and
catheter pressure.
2.6.2 Finite-element model results
Material properties for four canine subjects were fitted using a left-ventricular passive
inflation simulation in Continuity (Table 2.7). The optimized values for all subjects were
notably dissimilar from the reference values. S1 had much different values than the other
subjects, likely caused by its significantly greater chamber volume. The average least squares
error was 0.21, ranging from 0.09 to 0.30. Figure 2.8 shows the resulting unloaded meshes
and EDPVR curves for all four subjects.
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Figure 2.8 Results from simulated inflations of four canine left ventricles. (A) The final
unloaded meshes. (B) Comparison of the optimized simulated pressure-volume
curves to the Klotz curves (Klotz et al., 2006).
The largest impediment to fit was the allowed EDV convergence error for the estimation
of the undeformed ventricle geometry. The average solution took 76 hrs with 1277 eval-
uations, each requiring 2-3 inflation deflation iterations; however the number of required
unique evaluations varied widely between 374 and 3092, with repeat configurations used the
previously logged result for efficiency.
Table 2.7 Optimized coefficients from Eq. 2.9 and Klotz curve (Klotz et al., 2006) fit for
each canine subject.
Subject a af b bf Objective
(kPa) (kPa) - - -
ref 1.5 15 8 15 -
S1 1.6 5.1 7.3 4.5 0.30
S2 0.1 11.1 4 14.3 0.22
S3 0.3 6.8 4.3 12.7 0.09
S4 0.4 4.8 4.5 43.5 0.21
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2.7 Discussion
Our results showed that the proposed optimization-based tuning framework avoids many
of the issues inherent to manual tuning. Circulatory and finite-element models were tuned
for individuals with widely-varied parameters, but acceptable solutions were found for all
of them. It would be very time-consuming and tedious to manually tune these models from
a standard set of assumed parameter values in each case without considerable experience.
In addition, the manual process does not ensure repeatability of the parameter results.
Evaluation of the manual tuning performed by Krishnamurthy et al. (2013) on CircAdapt
models of the same patients used in this study resulted in an average objective of 2.42e-3,
97% higher than even the worst result from our method; pressure was the largest error
contributor. In addition, the manual process was significantly slower, with each patient
requiring up to 3 to 4 days of manual tuning. Our optimized parameter values were also
very different between individuals, suggesting that immediate local optima were avoided.
We showed how the adaptation of idealized reference values to patient-specific data can be
seamlessly integrated, thereby allowing for missing data.
One of the main insights that we obtained during implementation of the framework
is that the objective function for the circulation model optimization had to be carefully
selected. Just including Pmax and EDV alone as part of the objective function were not
enough to obtain consistent optimization results. Without the addition of the other penal-
ties, primarily from reference values, the resulting P-V loops were highly unrealistic in both
shape and position. We also found that an appropriate QRS duration value was vital to
avoid model artifacts caused by incorrect fill timing. In support of our hybrid global ap-
proach, early searches for local CircAdapt solutions produced unusable results; this shows
that some of the previous methods in the literature, such as NMS and Levenberg-Marquardt,
may not be appropriate for certain patient-specific parameters in our optimization. Gen-
erally, local optimizers that are heavily influenced by initial assumptions offer improved
convergence and precision; however, they can also increase the likelihood of issues due to
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sensitive parameters common in PSM which can easily be initialized in a non-global basin-
of-attraction. We were also surprised that the optimized canine material parameters in the
FEA model all converged to apparently reasonable values with the initially-assumed loose
bounds, suggesting that it is possibly a convex problem or that typical material parameters
give relatively good results for a wide variety of individuals.
Though the proposed framework addressed many of the issues currently impeding the
use of patient-specific cardiovascular models, there are still some key limitations to its
application. The first is that the use of noninvasive data imposes limitations on accuracy and
data acquisition. However, requiring invasive procedures reduces the value of the framework
as compared to more traditional explorative methodologies. The most efficient response is
to determine the data sources which are most sensitive and justify the most effort to capture
accurately. In the circulatory optimization, kMAP , Sfact, and kLV were the most sensitive
parameters; all had mean-normalized standard deviations less than half the value of any
other parameter. The values of these parameters are strongly correlated with Pmax and
EDV , which is not surprising as those metrics were most heavily weighted in the objective,
meaning that the accuracy of those reference measurements will have a large effect on the
results of the optimization.
We found that non-invasive measures of Pmax were especially unreliable, and this has
also been documented in the literature (Raamat et al., 2013). Obtaining pressure through
catheterization is currently ideal for data reliability, but improvements in non-invasive mea-
surement methods are necessary to enable the broader application of PSM. Along with the
approach of averaging MAP and Sfact discussed in the Results section, we also tried using
diastolic cuff pressure as a reference for aortic diastolic pressure. However, none of these
methods had a lower RMSE compared to the catheterized pressure measurements. These
results can be found in the Supplemental section.
Another limitation is that it is generally impossible to prove that a global optimum has
been found for non-convex non-analytical problems, so there is always the potential for a
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slightly better tuned result. It is also still necessary that an appropriate objective function
be manually constructed to evaluate model fit, which can often be surprisingly difficult.
This problem decreases in significance as the specific application of a model becomes more
widespread; in such cases a ”state-of-the-art” objective function and parameter bounds can
be shared among researchers and clinicians without requiring local expertise.
In summary, this framework can facilitate the widespread use of patient-specific or
subject-specific models by enabling tuning from non-invasive data. The optimization meth-
ods employed are resource efficient and easily scalable to the needs and computational
capacity of the application. Using an optimization framework, the information learned in
the medical community can be easily and reliably distributed, making it relatively easy to
tune a new patient model in a clinical environment compared with current manual meth-
ods. Finally, the framework is also usable in a research setting, where a major concern
in cross-species research is maintaining a consistent protocol. By tuning both human and
canine circulatory models with no modifications to the implementation besides reference
parameter values we demonstrate that this concern can be naturally addressed. This work
can be used in cross-species research and contribute to improved treatment of CVD.
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2.9 Appendix: Supplemental Methods and Validation
Performance of the circulatory model optimization was highly dependent on the quality
of the patient-specific pressure data. In the absence of reliable pressure data, we tried
different methods that can be used to still obtain a patient-specific pressure time-course.
This section outlines three other methods with corresponding validation plots comparing
their results with catheter data - the highest quality data available. Table 2.8 contains the
RMSE between the model and catheter data for all approaches.
The original method discussed in the paper uses systolic cuff pressure as a target value
for simulated peak LV pressure. Though the resulting pressure errors were within 0.53% of
the reference cuff pressure, a more fundamental issue was identified regarding the limitations
of cuff pressure accuracy. Figure 2.9 shows the resulting model LV pressure curves of the
initial optimization formulation validated against experimentally-obtained catheter data.
The peak pressure values differ significantly, leading to a high average RMSE of 3.12 kPa.
To minimize the variance in cuff pressure readings, we used the average optimized values
of MAP and Sfact - the two parameters with the strongest effect on Pmax - for all patients.
That result can be seen in the paper (Fig. 2.6).
Another approach we investigated was to use cuff diastolic pressure as the reference
value for simulated aortic diastolic pressure, instead of optimizing for peak LV pressure; the
form of the objective formulation was unchanged. The result can be seen in Figure 2.10.
This approach improved some patient models (C and G) and negatively impacted others
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Table 2.8 RMSE between human model and catheter data when either cuff (with or with-
out using the mean values of MAP and Sfact in x) or catheter pressure is used as
an optimization input and when modeled aortic diastolic pressure is optimized
against cuff diastolic pressure.
Patient Cuff Mean Aorta Cath
(kPa) (kPa) (kPa) (kPa)
A 4.07 2.90 5.59 2.41
B 2.66 2.57 2.97 2.75
C 2.85 2.53 2.49 2.78
D 4.59 4.08 6.07 3.28
E 3.11 1.53 3.66 0.97
F 3.48 3.29 6.02 1.43
G 2.79 4.44 1.97 1.39
H 1.42 1.55 1.42 1.42
(e.g. A and F), but increased average RMSE by 21%. This implies that diastolic cuff
pressure is no more reliable of a measurement than systolic cuff pressure.
Finally, we performed the optimization using the LV catheter data directly as a refer-
ence for peak LV pressure. In Figure 2.5, it can be seen that the model and optimization
framework are capable of generating realistic and accurate LV pressure curves given a re-
liable value for peak pressure. Improvements to non-invasive blood pressure measurement
techniques are needed to ensure results of this quality.
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Figure 2.9 Validation of the simulated left ventricular pressure curves optimized using
systolic cuff pressure for the eight human patients with catheter data. Gray
lines show cuff measurement systolic and diastolic pressures - only catheter
pressure was available as the reference for Patient H.
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Figure 2.10 Validation of the simulated left ventricular pressure curves for the eight hu-
man patients with catheter data after optimizing with measured diastolic cuff
pressure as a reference for aortic diastolic pressure. Gray lines show cuff mea-
surement systolic and diastolic pressures - only catheter pressure was available
as the reference for Patient H.
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CHAPTER 3. OPTIMIZATION FRAMEWORK FOR
PATIENT-SPECIFIC MODELING UNDER UNCERTAINTY
This paper is in review for The International Journal for Numerical Methods in Biomed-
ical Engineering. It was authored by Joshua Mineroff, Balaji Sesha Sarath Pokuri, Adarsh
Krishnamurthy, and Baskar Ganapathysubramanian. I was responsible for developing, im-
plementing, and testing the sampling and optimization framework as well as for writing the
majority of the manuscript. Balaji contributed the surrogate generation code and most of
the matching section of the paper. Adarsh informed the scope of the paper and supported
relevance to the field of cardiac modeling. Baskar helped create the approach and advised
on methodological decisions.
3.1 Abstract
Tuning of computerized models relies on data that is often unreliable and ill-suited
to a deterministic approach. We develop an optimization-based uncertainty quantification
framework for probabilistic model tuning that discovers distributions of model inputs which
generate target output distributions. Probabilistic sampling is performed using a model
surrogate for computational efficiency and a general distribution parameterization is used
to describe each input. The approach is tested on four patient-specific modeling examples
using CircAdapt, a cardiac circulatory model. Three examples are synthetic, aiming to
match the output distributions generated using known reference input data distributions,
while the fourth example uses real-world patient data for the output distributions. Our
results demonstrate accurate reproduction of the target output distributions, with accurate
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recreation reference inputs for the three synthetic examples. Although further testing is
needed to prove generalizability of the method, it appears suitable for the tuning of models
with uncertain data.
3.2 Acknowledgements
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3.3 Introduction
Computational models can be used to more efficiently and thoroughly understand a
complex system than experiments at reduced cost. While many aspects of these simulations
are idealized or analytically formulated, certain components require manual or automated
tuning of model parameters to accurately capture the modeled system. The values of these
parameters are often determined using experimental or reference data, either directly or
indirectly via dependent model values. However, available data is often unreliable; this
uncertainty impedes consistent tuning and must be accounted for to fully determine the
accuracy and validity of a result.
There are many ways to control or understand variability, but methods can be broadly
divided into the categories of validation and analysis. Validation uses reliable data, extrinsic
to the model, to test for model correctness. This can provide exact accuracy measurements,
but redundant experimental data may not be available and the need for experimental data
negates a key benefit of physically-representative models. Sensitivity and uncertainty anal-
ysis aim to characterize the variability of a model intrinsically, and a comparison of these
mathematical methods was performed by Iman and Helton (1988). Sensitivity analysis
looks at the effect of each individual variable on the model to determine which parameters
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are most important, which helps to focus data collection to where it will be most valuable.
Uncertainty analysis, or uncertainty quantification (UQ), is the direct characterization of
model uncertainty resulting from uncertain inputs. Instead of obtaining a model output and
judging its accuracy, UQ provides a range of possible output values with the distribution
of their occurrence. Walker et al. (2003) investigated the conceptual integration of uncer-
tainty into models intended for decision support to help the user make informed choices.
Mathematical methods of UQ are not especially new, but the transition to domain-specific
application has been slow.
One growing application of uncertainty classification in models is the use of patient-
specific modeling (PSM) in the study and practice of medicine. PSM is the use of patient-
specific data to individualize biomedical models. Information derived from such models can
inform medical interventions by providing clinicians with more accurate and comprehensive
diagnostic information as well as the predicted effects of different treatment modalities (Neal
and Kerckhoffs, 2009); it also introduces the potential to automate aspects of clinical de-
cision making, improving treatment consistency. Computational PSM continues to rise in
importance as the understanding of diseases and availability of diagnostic and treatment
options becomes more complex, and practicing physicians have to rely more on specialists
outside their area of expertise (Shortliffe et al., 1979). Additionally, a significant level of
training is currently required to initialize and operate them. Models used for PSM continue
to increase in complexity, magnifying uncertainties in model inputs. However, tuning ap-
proaches are often still deterministic and do not account for this variability (Krishnamurthy
et al., 2013; Ellwein et al., 2013; Reinbolt et al., 2008).
Treatment of cardiovascular disease (CVD), the leading cause of death in developed
countries (Roth et al., 2015), can significantly benefit from PSM and some such models are
already being tested in clinical settings (Niederer et al., 2009; Kerckhoffs et al., 2008). The
highly sophisticated models needed for patient-specific cardiovascular modeling rely on a
large number of uncertain data and can be expensive to validate. UQ has been applied
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to cardiovascular model tuning, though there is still no standard approach. Huberts et al.
(2018) propose a method to make uncertain cardiovascular models more useful for diag-
nosis and intervention based largely on sensitivity analysis. Sankaran and Marsden (2011)
perform UQ for a variety of geometric cardiovascular models using a stochastic collocation
approach. Xiu and Sherwin (2007) used a generalized polynomial chaos expansion method
for UQ in a 1D model. Further deployment depends on the development of efficient and
consistent model tuning methodologies.
We propose a general framework for probabilistic model tuning with uncertainty quan-
tification and test it using a cardiovascular circulatory model, CircAdapt (Arts et al., 2005).
The CircAdapt model is used to find input parameter distributions such that expected model
output distributions match those of experimentally measured non-invasive patient-specific
data. Parameterization of model variable distributions is done without any assumptions
of the form of those distributions. Since CircAdapt is a deterministic model, probabilistic
sampling of the model inputs was needed to get a distribution of outputs. To make the
necessary volume of evaluations computationally tractable, a surrogate model was built
using the PARyOpt framework (Pokuri et al., 2018). The combination of these techniques
supports accurate, efficient uncertainty analysis of expensive models.
The main contributions of this work include the development of:
1. An optimization framework for uncertainty quantification of model parameters.
2. A methodology for the estimation of uncertain patient-specific biophysical model pa-
rameters.
3. An efficient implementation of input distribution parameterization using deterministic
surrogates.
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Figure 3.1 A flowchart of the Design Under Uncertainty (DUU) framework.
3.4 Framework for Design Under Uncertainty
Inverse models are tuned by determining model input parameters such that model out-
puts match with available data. The error inherent in this data mean that a deterministic
approach is not ideal. Our Design Under Uncertainty framework (DUU, Fig. 3.1) is de-
signed to tune computerized models using uncertain data and builds on the methodology
developed by Mineroff et al. (2018). Specifically, the goal of the framework is to determine
the distribution of model inputs that match expected model output distributions. The
primary components of the framework are the probabilistic sampling method, the efficient
surrogate, the optimizer, and the original model.
3.4.1 Probabilistic parameterization and sampling
Probabilistic variables require more parameters to fully characterize than deterministic
variables. This necessitates the selection and development of an appropriate distribution
to accurately parameterize a probabilistic variable. Certain distributions can be described
with as few as two parameters per variable, e.g. mean and standard deviation for a normal
distribution; however, there are many different probability distributions used to describe
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uncertainty, even in the limited case of patient data (Gordon et al., 1983; Kuikka et al.,
1974). General parameterization schemas allow for any of these distributions to be discov-
ered when tuning the model. The proposed framework describes the distribution of each
model variable with parameter values representing probabilistically-uniform variable values
on the CDF. This approach supports a wide range of distributions, including deterministic
variables, and trivial parameterization refinement for more sensitive variables. Since p = 0
and p = 1 correspond with the values that are probabilistically guaranteed to be the lower
or upper bound of x they tend to attract towards negative and positive infinity, respectively.
To avoid this, we confine our representation and sampling of the CDF between p = 0.01
and p = 0.99.
There are a few ways to implement the proposed distribution parameterization for a
model variable x. The most straightforward method is to have N parameters that directly
represent the values of x at evenly spaced probabilities on the CDF. To ensure a valid
solution, each xn is bounded by the same bounds as x and N − 1 constraints are required
to ensure that the resulting CDF is monotonic. Another approach is for x1 to directly
represent the lower bound of the distribution, while all subsequent parameters represent
the increase in x over a given probability interval. If all parameters starting with x2 are
bounded to be positive, this decreases the required number of constraints per variable to 1
which ensures that the sum of all parameters representing x satisfies the upper bound of the
model parameter. Both of these approaches can be effective, but the need for constraints
makes them more expensive.
Our approach adds an extra parameter to the description of each model variable to
remove the requirement for constraints. In this approach, x1 represents the value corre-
sponding to p = 0.01. An additional N−1 parameters, bounded between 0 and 1, represent
the relative sizes of increments between x1 and xN . An additional parameter, bounded
between 0 and 1, scales the length between x1 and the upper bound of x. A value of 0 for
this parameter means that xN = x1, while a value of 1 means that xN equals the upper
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Figure 3.2 A representative example of a tuned model. (A) Parameterization of an input
variable distribution, where n = 5. (B) Error fitting of the simulated result
with a reference CDF.
bound of x. A representation of this parameterization is shown in (Fig. 3.2A). This allows
an potential distribution of x to be represented without the need for constraints.
Since many models are deterministic, there is often no way to directly evaluate a prob-
abilistic variable. This necessitates the sampling of deterministic variable values from the
described distribution. By Borel’s law of large numbers, a large number of samples eval-
uated in this way will generate an accurate output distribution. The parameterization
previously described has the benefit that arbitrarily accurate probabilistic sampling can be
performed cheaply by evaluating model values located probabilistically-uniformly along the
CDF. Multiple probabilistic inputs can be sampled in this way, but must be combined in
a way that avoids false correlation effects. We take the tensor product of the samples for
each input to get a complete set of samples, which assumes that the variables are mutually
independent.
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3.4.2 Surrogate modeling
Probabilistic models are generally represented in terms of a non-parameterized CDF
developed through multiple evaluations using probabilistically represented variables. This
complexity means that probabilistic model evaluation is significantly more expensive than
that of the same deterministic model. Additionally, each previously deterministic variable
now requires multiple parameters for a probabilistic representation – if 20 parameters are
used to represent each input distribution, then optimization of a 3 parameter deterministic
model expands to a 60 parameter problem. Thus methods need to be devised to reduce the
total number of resource-intensive cost function evaluations.
There are several methods available to tackle such high-dimensionality optimization
problems. A common technique (Leifsson et al., 2014; Robinson et al., 2008) is to consider a
reduced-order model representation for global optimization, which can substantially reduce
total optimization cost as the reduced-order cost function is cheaper to evaluate than the
original. However, this introduces a potential limitation – when reduced-order models do
not exist or have very low fidelity, the high-fidelity optimization is required. Therefore, to
take advantage of this technique and ensure broad applicability of the proposed framework,
a generalized method is needed to construct a cheap, reduced-order “meta-model” which
captures the response surface of the cost function.
There are several techniques to create a meta-model; the most common being interpola-
tion with varying degrees of continuity – this includes splines (Friedman, 1991), polynomial
interpolation (De Boor and Ron, 1990), and finally Gaussian processes (Dyn et al., 1986;
Fang and Horstemeyer, 2006). In this work, we use Gaussian process modeling to effi-
ciently build the reduced-order surrogate. It should be noted that an efficient meta-model
also implies efficient sampling when constructing the meta-model, not just efficient polling.
Gaussian processes, like radial basis function based Kriging (Cressie, 1988), offer this ad-
vantage over other techniques by providing a natural way to quantify informativeness of
different input configurations. Secondly, Gaussian processes absorb all data locations with-
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out over-fitting, so the generated surrogate will be an interpolant rather than a regression,
preserving the original cost function evaluations.
In this work, we use Kriging to create a meta-model of the cost-function. Kriging is
a general interpolation technique based on Gaussian priors and posteriors on functionals
aimed at approximating a, typically expensive, ‘oracle’ function. The approximate function
is described in terms of the mean and variance of distribution of the functions. Based on this
description, an informativeness metric is defined, commonly called the acquisition function;
locations with maximum information addition have a large value of acquisition function and
vice-versa. The ‘oracle’ function is then evaluated at these extrema of acquisition function
and the values are used to construct a posterior distribution. Mathematically, the algorithm
can be described as follows:
The surrogate/meta-model is constructed in the form:
y˜(x) =
∑
i=1,2,..N
wi k(xi,x) (3.1)
where k(xi,x) is a kernel function. The constructed meta-model (mean µ and variance
σ), after N function evaluations is given by
µ(xN+1) = k
TK−1y1:N (3.2)
σ2(xN+1) = k(xN+1,xN+1)− kT K−1 k (3.3)
where
K w¯ = y (3.4)
Ki,j = k(xi,xj), i, j ∈ [1, N ] (3.5)
yi = y(xi), i ∈ [1, N ] (3.6)
w¯ = {wi}, i ∈ [1, N ] (3.7)
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and
k = k(xN+1) = [k(x1,xN+1) k(x2,xN+1) ...k(xN ,xN+1)] (3.8)
To perform the above tasks, we use an in-house software, PARyOpt (Pokuri et al.,
2018), which performs parallel cost function evaluations asynchronously, enabling multiple
simultaneous function evaluations and can be deployed locally or on a HPC cluster, with
resilience to hardware failures. It is fully modular and ‘oracle’ function agnostic and it can
deal with ‘oracle’ failures – i.e., if the simulation is infeasible at a particular location, it can
still assimilate that location with an explicit ‘tag-of-failure’ associated with the infeasible
point. This feature of assimilating failed points is particularly handy when infeasibility of
evaluation locations cannot be estimated a priori.
3.4.3 Optimization framework
Complex models of real-world systems tend to be multi-modal and highly corrugated.
This, combined with the probabilistic model sampling necessary in each evaluation, makes
the calculation of gradients intractable and supports a derivative-free approach. We employ
a two-step approach; first using particle swarm optimization to perform a global search
of the problem space, and finally using pattern search to converge to a precise local op-
tima. The optimization and surrogate sampling for each evaluation is performed using
MATLAB (MathWorks, 2017). This methodology and implementation is efficient enough
to make local model tuning on a consumer laptop feasible.
The correctness of each model output is calculated using the RMS error between the
simulated output inverse-CDF (iCDF) and the predetermined target output iCDF, defined
using a combination of patient and reference data (Fig. 3.2B). Since models are often tuned
using more than one piece of output data as a target, the objective function needs to allows
for the consideration of multiple model output distributions. The selected optimization
formulation (Eq. 3.9) supports this by using a linear combination of the output RMS errors.
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arg min
x
N∑
n=1
an
√√√√ 1
M
M∑
m=1
(CDFmn(x)− rCDFmn)
s.t. E(fn(x)) = 0, for all n (*Surrogate of ODE solution),
Ax ≤ b (Bounds on x)
(3.9)
*Note that surrogate accuracy is actually better than an expected value of 0. Pointwise
the kriged model is exactly correct at the location, and within some region, of sampled
points.
3.5 Circulatory Model
3.5.1 CircAdapt
CircAdapt (Arts et al., 2005) is a lumped-parameter model of the circulatory system
(Fig. 3.3) implemented in MATLAB. It provides detailed information on hemodynamic
properties within the heart at any time during the cardiac cycle. We consider the model
variables and outputs identified as most important by Mineroff et al. (2018) (Table 3.1)
along with select patient data.
Table 3.1 Details and bounds of the different CircAdapt variables affected by x.
Variable Description Lower
Bound
Upper
Bound
Units Reference
kMAP Scaling of mean arterial pres-
sure initially calculated using
the ’33% formula’
0.8 1.2 - (Raamat et al.,
2013)
kLV Geometric scaling factor of left
ventricular midwall surface area
from CircAdapt reference con-
figuration
0.5 2 - (Clay et al.,
2006)
Sfact Maximum isometric active
stress of myofibers
25 200 kPa
Sfpas Passive stiffness of myofibers 10 30 kPa
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Figure 3.3 A schematic, showing geometric parameters, and output P-V loop, showing
the deterministic metrics, of the CircAdapt model. (A) A schematic of the
CircAdapt model highlighting key geometric dimensions of major model com-
ponents. (B) A typical simulated left ventricular (LV) pressure-volume loop
showing both metrics. Pulm. = pulmonary circulation; Syst. = systemic cir-
culation; LA = left atrium; RA = right atrium; RV = right ventricle; EDV =
end-diastolic volume.
3.5.2 Clinical data
The human patient studied was male, aged (approximately 66 years) with NYHA class
III heart failure, dilated cardiomyopathy, and left bundle branch block (LBBB) and enrolled
from the Veteran’s Administration San Diego Healthcare System (San Diego, CA). Patient
gave informed consent to participate in the human subject protocol approved by the insti-
tutional review board. Key cardiac measurements were recorded via echocardiogram and
routine diagnostic methods.
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Table 3.2 Summary of synthetic examples. In Example 2, the bolded distribution of input
X2 is known by the optimizer.
Example Unknowns Knowns X1 X2 Output 1 Output 2
1 1 0 kMAP - PmaxLV -
2 1 1 kMAP Sfact PmaxLV -
3 2 0 kMAP kLV PmaxLV EDVLV
3.6 Synthetic Examples
Before using the proposed framework to solve a real problem, it is tested with some syn-
thetic examples where the input distribution is known a priori. Starting with the reference
CircAdapt model configuration, we assume an input distribution or set of distributions and
run a forward model to calculate any output metric CDFs. The goal is to find an input
parameterization that accurately reproduces the calculated CDF. We can then check how
closely the resulting input parameterization matches the input used in the forward model;
recovering the initial input implies uniqueness of the solution. By using a synthetic input
distribution to find the target CDFs, we know the optimization problem is solvable. These
input distributions are truncated at p = 0.01 and p = 0.99, to ensure that the distribution
can be recovered exactly.
Three synthetic problems were solved to test the DUU framework (Table 3.2). The
first uses one probabilistic input to generate one target CDF, while all other variables are
known and deterministic. The second adds a known probabilistic input which influences
the same output. This shows how the method handles interactions between probabilistic
variables. The third example uses two unknown probabilistic inputs to determine two prob-
abilistic outputs. In this case, each input primarily influences a different output, but there
are interaction effects between the two; this demonstrates optimization stability in multi-
dimensional problems. Convergence studies of variable parameterization were performed
for Examples 1 and 2.
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Figure 3.4 Results of Example 1.
3.6.1 Example 1: One unknown probabilistic variable
The first synthetic problem involves one unknown probabilistic variable and a single
probabilistic output metric. The variable used is kMAP (µ = 0.9, σ = 0.05), which directly
affects PmaxLV. Figure 3.4 shows the tuned result, while Figure 3.5 shows the convergence
with increasing values of N. Table 3.3 shows the RMS errors from the convergence study.
Table 3.3 Convergence results of iCDFs for Example 1.
N X1 Output 1
Variable RMSE Metric RMSE
- (kPa)
10 kMAP 3.4e-3 PmaxLV 2.78e-5
20 kMAP 3.1e-3 PmaxLV 1.57e-5
40 kMAP 3.0e-3 PmaxLV 1.26e-5
3.6.2 Example 2: One unknown and one known probabilistic variable
The second example adds a known probabilistic input. The newly introduced variable
is Sfact (µ = 1.344 kPa, σ = 0.036 kPa), which also affects PmaxLV. Figure 3.6 shows the
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Figure 3.5 Convergence of resulting input CDFs from Example 1.
tuned result, while Figure 3.7 shows the convergence with increasing values of N. Table 3.4
shows the RMS errors from the convergence study.
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Figure 3.6 Results of Example 2.
3.6.3 Example 3: Two unknown probabilistic variables and two probabilistic
outputs
The final example involves two unknown probabilistic input variables that primarily
drive two separate model outputs. The input-output pairing of kMAP and PmaxLV is the
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Table 3.4 Convergence results of iCDFs for Example 2. The distribution of X2 is exactly
known by the optimizer.
N X1 Output 1
Variable RMSE Metric RMSE
- (kPa)
10 kMAP 28.0e-4 PmaxLV 25.8e-6
20 kMAP 9.7e-4 PmaxLV 8.5e-6
40 kMAP 6.2e-4 PmaxLV 2.0e-6
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Figure 3.7 Convergence of resulting input CDFs from Example 2.
same as in Example 1. Now, the geometry scaling variable kLV (µ = 1.05, σ = 0.01)
is added, which influences EDVLV. Both inputs influence both outputs, so there is some
cross-over effect in the optimization. Figure 3.8 shows the tuned result, while Figure 3.9
shows the effect of increasing values of N.
3.7 A Real-World Problem Using Patient Data
In the real-world, model input distributions are not known a priori. To simulate this,
we again use the same combination of variables and outputs as in Example 3, but we now
describe Gaussian target CDFs directly using patient and reference data. The mean for
these CDFs is the value obtained from the patient, while the standard deviation comes
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Figure 3.8 Results of Example 3.
from documented measurement errors in the literature (Ribezzo et al., 2014; Gordon et al.,
1983). Figure 3.10 shows the tuned result, while Table 3.5 shows the resulting RMS errors.
Table 3.5 Results for the Real-World example.
Output 1 Output 2
Metric RMSE Metric RMSE
(kPa) (mL)
PmaxLV 5.68e-6 EDVLV 2.04e-4
I
3.8 Discussion
Our results show that the proposed framework reliably discovered distributions of input
parameters which accurately reproduce target output distributions. All four of the studied
tuning examples resulted in reasonable input distributions. The three synthetic examples
demonstrated that the the approach works with multiple probabilistic inputs, whether one
or more of those inputs are being tuned. Accurate reproduction of the original input
distributions in those examples also exhibits consistency and reliability of the tuned result.
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Figure 3.9 Variation of input CDFs from Example 3 with increasing values of N.
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Figure 3.10 Resulting input and output CDFs from a two-dimensional real-world prob-
lem, where both probabilistic inputs are tuned and do not have prior-known
solutions. The bounds of the plots of x1 and x2 represent the bounds of the
surrogate.
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The real-world PSM problem was solved with the use of patient data, further proving the
stability of the framework in non-idealized model configurations.
An unexpected discovery during testing of the framework was that many implemen-
tations of probabilistically-uniform CDF sampling will introduce errors caused by false
correlation when extended to multiple input variables. This is because the nature of the
CDF causes sample values to be monotonic. Randomization was initially used to combine
sample vectors, but this causes the optimization objective to become stochastic - preventing
convergence to a precise optima. The final implementation of multi-variable sampling, using
the tensor product, was selected due to this need for a deterministic sampling approach.
While our method was designed and tested to work with a broad range of models and
domains, there are still a few key limitations related directly to the tuned inputs. While the
algorithm was able to generate very good solutions for all examples shown, based on the
objective functions we defined, there is no computationally-tractable way to prove that the
solutions found are unique. This means that there may be other input distributions that
equally satisfy our objective, or produce a similar quality output distribution. Similarly,
there is no guarantee of a global optimum, which means that a better solution to the chosen
objective may exist. For these reasons, there will always be some potential for the tuned
distributions to arbitrarily differ from measurable values of the real-world modeled system.
Other limitations of the framework are inherent to the use of the surrogate. Though
the surrogate provides many benefits in terms of computational-efficiency and robustness, it
introduces the potential for divergence from the original model. The model sampling used
to build the surrogates for the studied examples were very dense, but it is difficult to define
the maximum error in the same units as the modeled output. This makes it impossible to
make any guarantees on the upper bound of inaccuracy at any unsampled location on the
surrogate. However, the surrogate will be exactly accurate at each sampled location and
some region surrounding it. Another limitation is that the bounds of the surrogate must be
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predetermined when it is generated. The issue with this is that it can be difficult to know
what value ranges will be needed to capture extreme tails of input distributions.
To summarize, the proposed framework enables further automation of model tuning with
uncertain data, increasing utility of computerized models in domains where reliable data is
expensive or unavailable. The use of a surrogate makes the methodology computationally
efficient, which allows even expensive models to be tuned in such environments. Our results
from tuning the CircAdapt model support the applicability of this tool for PSM in a clinical
setting with non-idealized inputs. This approach also has potential applications in broader
problems of model design.
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CHAPTER 4. SUMMARY AND CONCLUSION
This framework can facilitate the widespread use of patient-specific or subject-specific
models by enabling tuning from non-invasive data. The proposed approach enables further
automation of model tuning with uncertain data, increasing utility of computerized models
in domains where reliable data is expensive or unavailable. The optimization methods
employed are resource efficient and easily scalable to the needs and computational capacity
of the application. The use of a surrogate makes the methodology computationally efficient,
which allows even expensive models to be tuned in such environments.
Using an optimization framework, the information learned in the medical community
can be easily and reliably distributed, making it relatively easy to tune a new patient
model in a clinical environment compared with current manual methods. The framework
is also usable in a research setting, where a major concern is maintaining a consistent
protocol in cross-species research. By tuning both human and canine circulatory models
with no modifications to the implementation besides reference parameter values, it was
demonstrated that this concern can be naturally addressed. The application of this work
in cross-species research can contribute to improved treatment of CVD. There are also
potential applications in broader problems of model design.
Though the proposed framework addressed many of the issues currently impeding the
use of patient-specific cardiovascular models, there are still some key limitations to its
application. The first is that the use of noninvasive data imposes limitations on accuracy and
data acquisition. However, requiring invasive procedures reduces the value of the framework
as compared to more traditional explorative methodologies. The most efficient response is
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to determine the data sources which are most sensitive and justify the most effort to capture
accurately. UQ can then be used to mitigate the resulting decision uncertainty.
Additionally, while the algorithm was able to generate very good solutions for all ex-
amples shown based on the objective functions we defined, there is no computationally-
tractable way to prove that the solutions found are unique. This means that there may
be other input distributions that equally satisfy our objective, or produce a similar quality
output distribution. Similarly, there is no guarantee of a global optimum, which means that
a better solution to the chosen objective may exist. For these reasons, there will always be
some potential for the tuned values or distributions to arbitrarily differ from measurable
values of the real-world modeled system.
Other limitations of the framework are inherent to the surrogate. Though meta-models
provide many benefits in terms of computational-efficiency and robustness, they introduce
the potential for divergence from the original model. The model sampling used to build
the surrogates for the studied examples were very dense, but it is difficult to define the
maximum error in the same units as the modeled output. This impedes guarantees on the
upper bound of inaccuracy at any unsampled location on the surrogate. Another limitation
is that the bounds of the surrogate must be predetermined when it is generated. The issue
with this is that it can be difficult to know what value ranges will be needed to capture
extreme tails of input distributions.
This work could be further developed in a number of directions. One interesting addition
would be a tolerance for surrogate building. This would allow surrogate construction to stop
when it is good enough instead of requiring the potentially excessive number of evaluations
currently needed to expect accuracy over a broad domain. Specific to the domain of PSM,
there is also the potential to use objectives more directly related to physiology.
In summary, this work lays the initial foundation of an automated optimization frame-
work for patient-specific modeling with uncertainty quantification that could be applied in
a clinical setting to improve patient treatment and, most importantly, outcomes. It can
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also be used more broadly to support cross-species medical studies leading to more effec-
tive treatment options. Development of tools such as the proposed framework, along with
increasingly complex models, will substantially increase our understanding of diseases and,
thus, the standard of available medical care.
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